Evidence map›Paper›PMID 26261564›Full record

ArticleInternational journal of clinical and experimental pathology2015

Mandible ameloblastoma with lung metastasis: a rare case report.

Rui-Na Yang, Xin-Shuai Wang, Jing Ren, Yan-Fei Xie, Dan Zhou, Dong-Feng Ge, Xiao-Shan Feng, She-Gan Gao

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rui-Na YangDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Xin-Shuai WangDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Jing RenDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Yan-Fei XieDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Dan ZhouDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Dong-Feng GeDepartments of Pathology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
Xiao-Shan FengDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
She-Gan GaoDepartments of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology Luoyang 471003, Henan, P. R. China.
First Affiliated Hospital of Henan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ameloblastoma is the most common odontogenic epithelial tumor, which belong to benign neoplasms that present a painless course, and usually occur in the oromaxillo-facial region. Although the histopathological manifestation of ameloblastoma is benign, it has unique biological behavior, for example local invasion and recurrence repeatedly. A few case of ameloblastoma was locally aggressive growth, and rarely metastasis to other tissue, for example the lungs, lymph nodes, and spine. CASE REPORT: A 64-year-old Chinese man, diagnosed with metastatic ameloblastoma, was treated with palliative chemotherapy consisting of cyclophosphamide, doxorubicin, and cisplatin for six cycles, and radiotherapy for 50 Gy after the last cycle chemotherapy. During the surveillance CT scan after the therapy, the tissues of the tumor were nearly complete response.

conclusionThe purpose of this study was to report a case of a patient with a right mandible ameloblastoma that recurred repeatedly and metastasized into bilateral lung. After the chemotherapy and radiotherapy, the tissues of the tumor were nearly complete response. This case is interesting because it investigated the diagnosis and treatment of the malignancy ameloblastoma, as this may help diagnose and treatment for clinician to the metastatic ameloblastoma.

Indexed as

AmeloblastomaAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBiopsyChemoradiotherapyCisplatinCranial IrradiationCyclophosphamideDoxorubicinHumansImmunohistochemistryLung NeoplasmsMaleMandibular NeoplasmsMiddle AgedNeoplasm Recurrence, LocalBiomarkers, TumorCisplatinCyclophosphamideDoxorubicinAmeloblastomachemotherapymandiblemetastasis

Identifiers

PMID26261564
PMCPMC4525898
OpenAlexW1146209534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.